Stille AB: Interim Report Q3 2023
Stille AB (publ) publishes the report for the third quarter of the business year 2023. ”Strong sales growth, profitability and cashflow in the third quarter”, summarizes President and CEO Torbjörn Sköld.
Revenue increased in the third quarter by 17.7 percent to 70.1 MSEK (59.6) after strong growth from both business units. “I am pleased to see that our strong growth compared to previous year continued in the third quarter”, comments Torbjörn Sköld.
The gross profit amounted to 46.7 percent (45.1). Business unit Surgical Tables was affected by an unfavorable product and market mix, while Surgical Instruments was positively affected by the same factors. Operating profit amounted to 11.9 MSEK (7.2).
”Stille’s strategic goals remain. With our differentiated high-quality products within surgical instruments and c-arm tables, we focus on niche premium segments. 2023 continues to be strong - We deliver value to our customers, which creates good demand, strong growth and good cashflow”, concludes Stille’s CEO.
| MSEK | JUL-SEP 2023 |
JUL-SEP 2022 |
JAN-SEP 2023 |
JAN-SEP 2022 |
OCT-SEP 2022/23 |
JAN-DEC 2022 |
| Revenue | 70.1 | 59.6 | 217.6 | 184.5 | 279.5 | 246.3 |
| Gross Profit Margin, % | 46.7 | 45.1 | 44.6 | 45.1 | 44.8 | 45.3 |
| EBITDA, before one-time costs | 15.5 | 9.4 | 45.0 | 30.5 | 56.6 | 42.1 |
| EBITDA | 15.5 | 9.4 | 41.7 | 30.4 | 53.3 | 42.1 |
| Operating Profit, before one-time costs |
11.9 | 7.2 | 34.3 | 23.7 | 43.1 | 32.5 |
| Operating Profit | 11.9 | 7.2 | 31.0 | 23.6 | 39.8 | 32.4 |
| Operating Profit, % | 17.0 | 12.1 | 14.2 | 12.8 | 14.2 | 13.2 |
Torshälla, October 26th, 2023.
This information is such information that Stille AB is obliged to disclose according to the EU’s market abuse regulation. The information was, through the agency of the contact person, rendered for publication on October 26th, 2023, kl. 08.00 (CEST).
For more information, please contact:
Torbjörn Sköld
CEO and President
+46 (0)70 316 63 91 | torbjorn.skold@stille.se
Stille AB (publ) publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information, visit www.stille.se.